Skip to main content
. 2016 Nov 25;8(1):1278–1289. doi: 10.18632/oncotarget.13606

Table 2. Assessment of quality of studies by Newcastle-Ottawa Scale.

Studies Selection Comparability Outcome Total
1 2 3 4 5A 5B 6 7 8
Pastore 2015[21] * * * * * * * * 8
Grotenhuis 2015[10] * * * * * * * * 8
Wyszynski 2014[24] * * * * * * * * 8
Kim 2014[17] * * * * * * * * 8
Serretta 2013[11] * * * * * * * * * 9
Rink 2013[7] * * * * * * * * 8
Rink 2013[8] * * * * * * * * 8
Da Silva 2013[16] * * * * * * * * 8
Lee 2012[12] * * * * * * * * 8
Sfakianos 2011[18] * * * * * * * 7
Chade 2010[19] * * * * * * * 7
Ahirwar 2008[23] * * * * * * * * 8
Chen 2007[9] * * * * * * * * * 9
Leibovici 2005[20] * * * * * * * 7
Allard 1995[22] * * * * * * * 7

1 = Representativeness of the exposed cohort;

2 = Selection of the non-exposed cohort;

3 = Ascertainment of exposure;

4 = Demonstration that outcome of interest was not present at start of study;

5 = Comparability of cohorts on the basis of the design or analysis (a. study controls for age; b. study controls for any additional factor);

6 = Assessment of outcome;

7 = Follow-up long enough for outcomes to occur;

8 = Adequacy of follow up of cohorts.